Am. J. Respir. Crit. Care Med., Volume 160, Number 3, September 1999, 1009-1014

Analysis of MHC Encoded Antigen-processing Genes TAP1 and TAP2 Polymorphisms in Sarcoidosis

PATRICK J. FOLEY, PENELOPE A. LYMPANY, ELZBIETA PUSCINSKA, JAN ZIELINSKI, KENNETH I. WELSH, and ROLAND M. du BOIS

Interstitial Lung Disease Unit, Department of Occupational and Environmental Medicine, National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, London; Oxford Tissue Typing Centre, Nuffield Department of Surgery, The Churchill Hospital, Oxford, United Kingdom; and Institute of Tubercle and Lung Diseases, Warsaw, Poland

Sarcoidosis is a chronic granulomatous disease of unknown etiology. Several studies have suggested involvement of human leukocyte antigen (HLA) genes in sarcoidosis susceptibility. HLA associations described have not been consistent, possibly because of additional susceptibility genes adjacent to or within the major histocompatibility complex (MHC) such as genes for the transporter associated with antigen processing (TAP). The aim of this study was to analyze TAP gene polymorphisms in patients with sarcoidosis using the amplificatory refraction mutation system (ARMS) PCR. To determine whether any association between TAP gene variation and sarcoidosis was ethnic-independent we examined two European populations: 117 unrelated UK Caucasoid patients with sarcoidosis and 290 healthy UK control subjects, and 87 unrelated Polish Slavonic patients with sarcoidosis and 158 healthy Polish control subjects. We detected significant differences in TAP2 between the UK control and patient groups, and in TAP2 between the Polish control and patient groups. Comparing the UK and Polish control groups, we observed a difference in TAP1. Examination of HLA-DPB1 in our UK population showed no associations with disease or between variants at the TAP gene loci and HLA-DPB1 variants. These results suggest associations at the TAP loci occur independently of HLA-DPB1 associations, that TAP associations seen may be involved in determining sarcoidosis susceptibility, and that such susceptibilities differ between UK and Polish populations. This first study of TAP genes in UK and Polish sarcoid populations has demonstrated the importance of using multiple defined ethnic populations in defining the role genetic factors play in sarcoidosis susceptibility and the importance of candidate gene studies.

This article has been cited by other articles:

				N. Kaminski, J. A. Belperio, P. B. Bitterman, L. Chen, S. W. Chensue, A. M.K. Choi, S. Dacic, J. H. Dauber, R. M. du Bois, J. J. Enghild, et al. Idiopathic Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): S1 - 105. [Full Text] [PDF]

				M. C. Iannuzzi, M. J. Maliarik, L. M. Poisson, and B. A. Rybicki Sarcoidosis Susceptibility and Resistance HLA-DQB1 Alleles in African Americans Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1225 - 1231. [Abstract] [Full Text] [PDF]

				B. A. Rybicki, M. J. Maliarik, L. M. Poisson, R. Sheffer, K. M. Chen, M. Major, G. A. Chase, and M. C. Iannuzzi The Major Histocompatibility Complex Gene Region and Sarcoidosis Susceptibility in African Americans Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 444 - 449. [Abstract] [Full Text] [PDF]

				M. C. Iannuzzi, M. Maliarik, and B. A. Rybicki Nomination of a Candidate Susceptibility Gene in Sarcoidosis . The Complement Receptor 1 Gene Am. J. Respir. Cell Mol. Biol., July 1, 2002; 27(1): 3 - 7. [Full Text] [PDF]

				R. M. du Bois The Genetic Predisposition to Interstitial Lung Disease : Functional Relevance Chest, March 1, 2002; 121 (2009): 14S - 20S. [Abstract] [Full Text] [PDF]

				P. J. Foley, D. S. McGrath, E. Puscinska, M. Petrek, V. Kolek, J. Drabek, P. A. Lympany, P. Pantelidis, K. I. Welsh, J. Zielinski, et al. Human Leukocyte Antigen-DRB1 Position 11 Residues Are a Common Protective Marker for Sarcoidosis Am. J. Respir. Cell Mol. Biol., September 1, 2001; 25(3): 272 - 277. [Abstract] [Full Text] [PDF]

				G.M. Verleden, R.M. du Bois, D. Bouros, M. Drent, A. Millar, J. Muller-Quernheim, G. Semenzato, S. Johnson, G. Sourvinos, D. Olivieri, et al. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin Eur. Respir. J., July 1, 2001; 18(32_suppl): 17S - 29s. [Abstract] [Full Text] [PDF]

				J. Grunewald and A. Eklund Human leukocyte antigen genes may outweigh racial background when generating a specific immune response in sarcoidosis Eur. Respir. J., May 1, 2001; 17(5): 1046 - 1048. [Abstract] [Full Text] [PDF]

				M. SCHÜRMANN, P. A. LYMPANY, P. REICHEL, B. MÜLLER-MYHSOK, K. WURM, M. SCHLAAK, J. MÜLLER-QUERNHEIM, R. M. du BOIS, and E. SCHWINGER Familial Sarcoidosis Is Linked to the Major Histocompatibility Complex Region Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 861 - 864. [Abstract] [Full Text]

				D S McGrath, Z Daniil, P Foley, J L du Bois, P A Lympany, P Cullinan, and R M du Bois Epidemiology of familial sarcoidosis in the UK Thorax, September 1, 2000; 55(9): 751 - 754. [Abstract] [Full Text]